is toujeo a glp-1 Daily Medication Pearl: Insulin Glargine Injection (Toujeo) FDA approves first generic GLP-1
Description
JAMA Surgery, 160 (11), 1232-1239
doi: 10.2337/db13-0604 30 Lam-ChungCE
Abstract Background Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM)
GLP-1 Drugs and Risk for Losing Your Vision Ischemic retinopathy is a serious eye condition caused by insufficient blood flow to the retina, the light-sensitive tissue at the back of the eye
Sophisticated payers and PBMs track patent expiration dates actively to plan formulary transitions
Yet the race is on for the next generation, and we explore 10 promising new drugs in development
